JP Morgan Maintains Overweight on US Physical Therapy, Lowers Price Target to $99
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Calvin Sternick has maintained an Overweight rating on US Physical Therapy (NYSE:USPH) but reduced the price target from $108 to $99.
November 17, 2023 | 4:12 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan has maintained an Overweight rating on US Physical Therapy but lowered the price target from $108 to $99, indicating a positive outlook but with reduced expectations.
While the Overweight rating suggests that JP Morgan continues to see US Physical Therapy as a good investment, the reduction in the price target may reflect a tempered expectation for the stock's performance. This could lead to a neutral short-term impact as the positive rating is counterbalanced by the lower price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100